Classical dendritic cells (cDC) are specialized antigen-presenting cells mediating immunity and tolerance. cDC celllineage decisions are largely controlled by transcriptional factor regulatory cascades. Using an in vivo cell-specific targeting of Runx3 at various stages of DC lineage development we show that Runx3 is required for cell-identity, homeostasis and function of splenic Esam 
Introduction
Classical dendritic cells (cDC) are a sparsely distributed, migratory group of bone-marrow-(BM) derived immune cells specialized in antigen uptake and presentation [1, 2] and as such important mediators of immunity and tolerance [3, 4] . cDC are divided into two main groups: migratory DC (mDC) and stationary DC (sDC). mDC are scattered in most body organs including lung, gut and skin and act as sentinels by sampling environmental pathogens. Upon activation, mDC migrate to secondary lymphoid organs and present processed antigens to T cells. sDC, on the other hand, sample and process antigens directly in the lymphoid organs. These sDC are heterogeneous with respect to their cell-surface markers and function and have based on surface molecules been divided into three major types: XCR1 + CD8α + /CD4 -/CD11b -, CD4 + /CD11b + /CD8α -and CD4 − /CD8α − CD11b + [5] . In addition, splenic CD8α + and CD4 + subsets differ in MHCI and MHCII processing pathways, reflected in their ability to preferentially induce CD4 or CD8 T cell responses [6] . Despite their phenotypic and functional heterogeneity all splenic cDC are derived from a common DC precursor (CDP) [7] . BM CDP give rise to plasmacytoid DC (pDC) and circulating pre-DC that seed the peripheral tissues [7] . [8] . Several transcription factors (TF) affect DC lineage development and function. Mice lacking the TF Id2, Irf8 or Batf3 are deficient in CD8 + DC [9] [10] [11] and loss of Irf4 TF affects CD4 + DC development [12] . On the other hand, loss of the cDC-specific TF zDC (Zbtb46) [13, 14] did not impair DC development, but was associated with increased activation of naive cDC [15] .
Runx3 TF is highly expressed in mature BM derived cultured DC and mediates their response to TGF-ß [16] . Here we explored Runx3 function throughout DC lineage development using mice that lack Runx3 specifically in DC and their progenitors. Runx3 ablation at defined developmental DC stages led to largely impaired splenic CD4 
Methods

Mice
The Runx3 P1/P2-GFP KI and Runx3 -/-(KO) mice were previously described [17] [18] ( Figure 1A ). Mice lacking Runx3 in specific DC progenitors were produced by crossing Runx3 fl/fl mice [17] onto Cebpα-Cre mice [19] or CD11c-Cre mice [20] . This mating scheme generated Runx3 fl/fl /Cebpα::Cre (Cebpα-DC-Runx3 Δ ) or Runx3 fl/fl /CD11c:Cre (CD11c-DC-Runx3 Δ ) mice, respectively. C57BL/6 Ly5.2 mice were purchased from Harlan Laboratories (Rehovot). C57BL/6 Ly5.1 mice and TCR-transgenic mice harboring ovalbumin (OVA)-specific CD4 + or CD8 + T cells were bred in the Weizmann animal facility. For generation of BM chimeras C57BL/6 Ly5.1 mice were lethally irradiated (1050 Rad) and reconstituted by intravenous injection of 1:1 mixture of C57BL/6 Ly5.1 and CD11c-DC-Runx3 Δ BM cells. Mice were analyzed 6-10 weeks later. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Weizmann Institute of Science (Permit Number: 01190113-2). All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering.
Flow cytometric analysis
For analysis of BM DC precursors femurs and tibias BM cells were suspended in ACK erythrocyte-lysis buffer (0.15M NH4Cl, 0.1M KHCO3, and 1mM EDTA in PBS), washed and then stained with CD135 (A2F10), CD117 (2B8), CD115 (AFS98), and lineage Ab cocktail: CD11b (M1/70), CD3 (145-2C11), CD4 (GK1.5), CD8a (53-6.7), Gr1 (RB6-8C5), Sca-1 (D7), B220 (RA3-6B2), Ter-119, CD11c (N418), and NK1.1 (PK136). Splenic DC were obtained from spleens treated for 30 min with collagenase D (1mg/ml C5138 Sigma) and DNase I (20ug/ml Roche). DC were characterized using ACK-lyzed cell suspensions as CD11c hi MHCII + CD4/CD8α or CD11b/Esam/ CD8α. pDC were characterized as CD11c/PDCA1/B220 and monocytes as CD11b/CD115/Ly6c. DC subsets were analyzed for maturation by staining with CD40 (3/23) and CD86 (GL-1). Blood monocytes were detected as CD115/CD11b and Ly6C + or Ly6C -cells. DC were analyzed for apoptosis by annexin V and propidium iodide staining according to the manufacturer instruction (eBiosciences). All Abs were purchased from BioLegend or eBiosciences if not indicated otherwise. FACSAria flow cytometer (BD Biosciences) was used for cell sorting and forward scatter height versus forward scatter width appearance was used to exclude dublets. Analysis using LSRII flow cytometer (BD Biosciences) was conducted with FACSDiva Version 6.2 software (BD Biosciences). FACS data were further analyzed using FlowJo Version 9.3.2 software (TreeStar).
RNA isolation and microarray gene expression analysis
Total RNA from sorted DC was extracted using the miRNeasy Mini Kit (QIAGEN) including DNase digest (QIAGEN). RNA purity was assessed with a BioAnalyzer 2100 (Agilent Technologies). Samples of 250ng RNA from each isolated DC population was labeled and hybridized to Affymetrix mouse exon ST 1.0 microarrays according to manufacturer instructions. Microarrays were scanned using GeneChip scanner 3000 7G. Each experiment was conducted in duplicates or triplicates using RNA from independent FACS isolated cells. Statistical analysis was performed using the Partek® Genomics Suite (Partek Inc., St. Louis, Missouri 63141) software. CEL files (containing raw expression measurements) were imported to Partek GS. The data was preprocessed and normalized using the RMA (Robust Multichip Average) algorithm [21] with GC correction. To identify differentially expressed genes, One-Way ANOVA was applied. Differential gene lists were created by filtering the genes based on: absolute fold change >= 1.5, p <=0.05 and signal above background in at least one microarray (log 2 intensity >=6.5). Log 2 gene intensities were used for scatter plots (Partek) and matrix plots containing: correlation, histogram and scatter plots (using R language). Gene expression clusters for 224 transcripts were generated using log 2 ratios with the Expander SOM tool [22] . These transcripts were differentially expressed in our and in [8] experiments and were above background in both datasets. Microarray data is available at Gene Expression Omnibus (GEO) under accession numbers GSE48589 (Runx3 function in CD4 + splenic DC) and GSE48590 (The affect of specific ablation of Runx3 from Esam splenic DC).
ChIP-seq data acquisition and analysis
Two biological replicate ChIP-Seq experiments were conducted for detection of Runx3-bound genomic regions using in-house anti Runx3 Ab and 30x10 6 positive CD11c MACS isolated (Miltenyi Biotec) DC. These cells were further purified by FACS to CD11c
+ cDC subset. Isolated cells were fixed in 1% formaldehyde and sonicated to yield DNA fragments of ~300bp according to standard procedures previously summarized in [23] . For immunoprecipitation, 40ul of anti-Runx3 Ab were added to 15 mL of diluted, fragmented chromatin; whole cell extract fragmented chromatin served as control. DNA was purified using QIAquick spin columns (QIAGEN). For ChIP-seq analysis, Illumina sequencing of short reads (50 bp) was performed in one lane of Hiseq 2000 using v2 clustering and sequencing reagents. For data analysis 70 million Runx3 IP and 74 million whole genome extract sequences were aligned uniquely to the mouse genome (mm9) using bowtie [24] . Bound regions were detected using MACS2 [25] . Runx3 bound peaks and coverage data (bigWig files) were uploaded to the UCSC genome browser [26] . GREAT algorithm was applied to determine genes corresponding to Runx3-bound peaks and ontology enrichment analysis [27] . Cistrome CEAS [28] was used to calculate average profile read near TSS and to generate venn diagrams. De-novo discovery of TF binding sites was conducted using DREME [29] . Analysis of co-bound zDC -Runx3 peaks was done using bedtools [30] . Statistical evaluation of fold enrichment distributions was done using the R package. ChIP-seq data is available at Gene Expression Omnibus (GEO) under accession number GSE48588 (Genome-wide maps of Runx3 bound regions in CD4 + splenic DC).
RT-qPCR and Western blotting
Total RNA was reverse-transcribed using miScript reverse transcription kit (QIAGEN) according to manufacturer's instructions. Quantitation of cDNAs was performed by qPCR using Roche LC480 LightCycler with sequence-specific primers and miScript SYBR Green PCR kit (QIAGEN). Target transcript quantification was calculated relative to ACTB mRNA, which served as an internal control. Standard errors were calculated using REST [31] . For Western blot analysis FACS isolated DC sub-populations were collected, washed once in PBS, proteins extracted with RIPA buffer and analyzed by Western blotting with anti Runx3 Ab [17] . GAPDH was used as an internal loading control.
T-cell proliferation and Phagocytosis assays
CD4
+ and CD8 + OVA-specific T cells were isolated from spleens and lymph nodes of OT-II and OT-I TCR-transgenic mice and CD4 or CD8 cells isolated by MACS (Miltenyi Biotec). Cells were labeled with CFSE (Invitrogen) and coinjected into the tail veins of recipient mice (2 X 10 6 cells/mouse). Twentyfour hours later, 20ug of soluble OVA (Sigma-Aldrich) per mouse was injected. Analysis of T-cell proliferation in spleens of recipient mice was performed 96 hours following T-cell transfer. For phagocytosis assay 200µl of 2.66% solid Fluoresbrite Carboxylate were injected into the tail veins with FITC labeled 0.5µm latex microspheres (Polysciences, Warrington, PA). Analysis of splenic DC microspheres uptake was performed 5 and 18 hours following injection.
Statistical analysis
Statistical significance was determined with unpaired, two tailed Student's t test. To identify differentially expressed genes, One-Way ANOVA was applied. Spearman correlation between microarray intensities was calculated using the R package. zDC peaks were found to be overlapping Runx3 peaks more than expected by chance using the hyperbrowser [32] . Specifically the test applied preserved the zDC regions and the number of Runx3 peaks and randomized (Monto Carlo test) the positions of Runx3 peaks with a constrain to the same chromosome and to a similar distance from the TSS. Same p value resulted in the opposite test (i.e. randomizing the zDC peaks). Kolmogorov-Smirnov test was applied on the Runx3 peaks fold enrichment distributions using the R package (ks.test) (http://www.R-project .org/).
Results
Expression of Runx3 during DC lineage development
To determine the developmental stages of the mononuclear phagocyte lineage where Runx3 expression is acquired, we took advantage of mice harboring a GFP reporter gene in their Runx3 loci [17] ( Figure 1A ). Specifically, we analyzed BM resident myeloid precursors (CMP, MDP, CDP and pre-DC), as well as mature myeloid splenocytes, of compound transgenic Runx3 P1/P2-GFP (Runx3 P1-GFP/P2-GFP ) mice that report activities of the two known Runx3 promoters P1 and P2 [17] . Analysis of BM-resident DC-progenitor populations revealed substantial variation in the abundance of Runx3-expressing cells. Among the common myeloid progenitor (CMP) cells (Lin [8] .
Interestingly, a similar reporter gene expression pattern was detected in cells derived from either Runx3 P1-AFP/+ or Runx3 P2-EGFP/+ mice ( Figure S1A and E), indicating that Runx3 expression in BM DC-progenitor subsets and mature CD11c + CD11b + DC was driven by both P1 and P2 promoters. In summary, Runx3 expression was readily detected in subpopulations of BM CMP, MDP and pre-DC as well as in splenic CD11b + DC, whereas Runx3 expression was absent from CD8 + DC, monocytes and pDC populations.
Runx3 regulates development of splenic CD11b + DC
Because DC development is associated with alterations in Runx3 expression levels ( Figure S1A ), we addressed its role in DC lineage specification and homeostasis. Mice lacking Runx3 starting from the CMP or Pre-DC stage were generated by crossing Runx3 fl/fl mice [17] onto Cebpα-Cre mice [19] and CD11c-Cre mice [20] , respectively. To confirm efficient Runx3 ablation in these mouse models we performed a Western blot analysis on FACS-isolated CD4 + DC of wild-type (WT) mice, Runx3 
Runx3 is required for lineage identity and homeostasis of Esam hi DC
To elucidate the cell-intrinsic regulatory role of Runx3 during splenic CD4
+ DC homeostasis we sought to identify Runx3-responsive genes driving this process. Comparison of Runx3 -/-and WT CD4 + DC expression profiles revealed 412 differentially expressed genes ( Figure 3A and Table S1 ). Significantly, several of these Runx3-responsive genes had previously been implicated in DC lineage development and homeostasis. For example, Irf8 [10] and Spic/PU.1 [33] were upregulated while Irf4 [12] was downregulated in Runx3-deficient CD4 + DC ( Figure 3A and Figure S3A Figure 3F and G) along with genes such as Kit and Itgax that were downregulated upon loss of Runx3 ( Figure 3B and G Figure S3D ).
Identification of Runx3-regulated genes in splenic CD4
+ DC
We next sought to identify among Runx3-responsive genes those that were directly regulated by Runx3 and could therefore contribute to the cell-phenotypic shift of Esam hi DC to Esam low DC. ChIP-seq was conducted using FACS-isolated CD11c hi MHCII + CD4 + splenic WT DC and anti-Runx3 antibodies (Ab). Data analysis revealed that of the 15121 Runx3-bound regions 9938 were associated with annotated genes ( Figure  4A ). Location analysis of these Runx3-occupied regions relative to the nearest transcription start sites (TSS) of the annotated genes, revealed that ~50% were placed ±10kb from a gene TSS (Figure S4A and B) . Runx3 ChIP-seq data analysis using GREAT [27] indicated that Runx3-bound regions were highly enriched for genes that belong to specific functional categories, including antigen processing and presentation ( Figure S4C ). To identify among the CD4 + DC Runx3-responsive genes those that were Runx3-regulated we cross-analyzed Runx3 ChIP-Seq and differential gene expression datasets. Of the 412 Runx3-responsive genes 316 were bound by Runx3 and defined as Runx3-regulated ( Figure  4A ). Forty percent (127) of these Runx3-regulated genes belonged to the subset characteristic of WT CD11b Sequence analysis revealed that 86% of Runx3-occupied genomic regions contained the canonic RUNX motif TGTGGT ( Figure 4C ). Interestingly, Runx3-bound regions were also enriched for the motif TGACGT comprising the binding site of DC-specific TF zDC/zbtb46 [15] (Figure 4C ). Moreover, comparison of the published zDC ChIP-seq dataset [15] to Runx3-occupied regions in splenic CD4 + DC revealed that a high proportion (66%) of zDC bound genes was co-bound by Runx3 and that the zDC/Runx3 co-occupied regions were significantly enriched in Runx3 binding ( Figure S4D ). This observation is consistent with the possibility that Runx3 and zDC cooperate in regulating DC specific gene expression particularly as similar to Runx3, zDC participates in homeostasis of splenic CD4 + DC [13] .
Runx3 is required for CD4 + DC-mediated T-cell priming
T cell priming and activation by DC link innate and adaptive immunity and modulate tolerance vs. immune response. CD4 + T cells are preferentially primed by CD4 + DC in a MHC-II dependent manner [6, 34] . CD4 + DC-dependent T cell priming was reported to be impaired in DC-Rbpj Δ mice that lack CD11b + Esam hi DC [8] , raising the possibility that also the Runx3 Δ -dependent phenotypic shift of CD4 + T cell priming in DC-Runx3 Δ mice is most probably due to an intrinsic cell defect in the Esam hi CD4 + DC. Consistent with this conclusion, Runx3 bound ( Figure 5C ) and regulated expression ( Figure  S4C ) of classical MHC-II genes and its loss could therefore affect MHC-II presentation. Together, the data indicate that Runx3 not only participates in promotion and maintenance of Esam hi DC identity, but also contributes to their CD4 + T cell priming activity.
Reduced phagocytic capacity of Runx3-deficient splenic CD11b + DC DC-mediated adaptive immune responses involve antigen phagocytosis followed by MHC-dependent T cell priming. The crucial contribution of Runx3 to the ability of Esam hi CD4 + DC to prime CD4 + T cells posed the question as to whether it was also required for phagocytic DC activity. To directly evaluate this possibility we injected 1x10 10 FITC-labeled latex beads to WT and DC-Runx3 Δ mice, and monitored uptake of fluorescent beads by splenic DC, 5 and 18 hours later ( Figure 5A and Figure S5B ). Of note, Runx3 Δ CD4 + /CD11b + DC displayed a reduced capacity to phagocytose the beads compared to WT CD4 + /CD11b + DC, while Runx3 Δ CD8 + DC exhibited phagocytic capacity similar to WT DC ( Figure 5D ). Moreover, when we divided the CD11b + DC population and analyzed the phagocytic ability of WT Esam hi and Esam low DC independently, we found that Esam hi DC exhibited a higher phagocytosis potential than their Esam low DC counterparts ( Figure 5E and Figure 5B ). However, this higher phagocytic capacity of WT Esam hi DC diminished upon Runx3 ablation ( Figure 5E and Figure S5C ). Even more convincingly, injection of 1x10 10 
Discussion
Extensive efforts have been made over the past decade to elucidate the mechanisms underlying the production of DCprogenitors and to delineate the heterogeneity and functions of their downstream lineage cell subsets [7, 35, 36] . However, information about the role of specific TF in DC development, subset specification and homeostasis is still incomplete. Using Impaired Homeostasis of Runx3-/-CD11b+Esamhi DC PLOS ONE | www.plosone.org + T cell priming capacity, as well as decreased phagocytosis.
The finding that in CD4 + DC the zDC/Runx3 co-bound regions comprised more than 50% of the genomic regions occupied by this recently identified DC-specific TF [15] suggest that the two TF cooperate in driving the CD4 + Esam hi transcriptional program and may collaborate in repressing Runx3-regulated Esam low DC genes. Of particular relevance to these recent findings is the observation that inactivation of the E2-2 TF during pDC maturation led to a major change in pDC gene expression [37, 38] so that E2-2-deficient pDC displayed induced or repressed expression of genes characteristic to CD8 + DC and pDC respectively [37] . Both TGF-β and Notch signaling pathways are important for DC development and function [20, 39] . These two pathways crosstalk through protein-protein interaction of Notch intracellular domain with Smad3 [40] . Fainaru et al. have shown involvement of Runx3 in TGF-β dependent DC function [16] and Runx3 participates in Notchmediated endothelial/mesenchymal transition [41] . Expression of the Esam receptor by CD11b + DC is regulated by the Notch2-Rbpj signaling [8] . Supporting Information Figure S1 . 
